1. Home
  2. Angel / Venture

Category: Symprove

Fledgling private equity house bd-capital picks probiotics pioneer Symprove for debut deal

Newly-launched private equity house bd-capital has sealed its first investment by backing Symprove, a startup attempting to disrupt the £35bn probiotics market.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.